Other

Dataset Information

0

Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia


ABSTRACT: To identify novel therapeutic targets in Acute Myeloid Leukemia (AML), we chemically interrogated 200 sequenced primary specimens. We identified Mubritinib, a known ERBB2 inhibitor, as a strong in vitro and in vivo anti-leukemic compound. We demonstrate that, in the context of AML, Mubritinib functions through ubiquinone-dependent inhibition of Electron Transport Chain (ETC) complex I activity. Resistance to Mubritinib characterized normal CD34+ hematopoietic cells and chemotherapy-sensitive AMLs, which displayed transcriptomic hallmarks of hypoxia. Conversely, sensitivity correlated with mitochondrial function-related gene expression levels and characterized a large subset of chemotherapy-resistant AMLs with oxidative phosphorylation (OXPHOS) hyperactivity. Altogether, our work thus identifies a novel ETC complex I inhibitor and reveals for the first time the genetic landscape of OXPHOS dependency in this disease.

ORGANISM(S): Homo sapiens

PROVIDER: GSE130906 | GEO | 2019/05/10

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-01-24 | GSE254173 | GEO
2017-06-25 | GSE97631 | GEO
2017-06-25 | GSE97393 | GEO
2018-10-05 | GSE120834 | GEO
2024-06-27 | GSE263238 | GEO
2015-03-01 | E-GEOD-45249 | biostudies-arrayexpress
2024-11-30 | GSE218229 | GEO
2021-11-12 | GSE183329 | GEO
2024-11-23 | GSE254939 | GEO
2014-03-19 | E-GEOD-54313 | biostudies-arrayexpress